脑深部刺激
认知
认知功能衰退
丘脑底核
痴呆
评定量表
疾病
队列
心理学
医学
中枢神经系统疾病
物理医学与康复
人口
神经科学
队列研究
阿尔茨海默病
退行性疾病
听力学
疾病严重程度
刺激
认知障碍
认知测验
脑刺激
儿科
睡眠剥夺对认知功能的影响
神经影像学
认知障碍
临床痴呆评级
发病年龄
前瞻性队列研究
临床试验
老年学
运动症状
病态的
帕金森病
原发性震颤
发展心理学
作者
Evridiki Asimakidou,Micol Avenali,Jan Olav Aasly,Mitra Afshari,Roy N. Alcalay,Sharlet Anderson,Carlo Alberto Artusi,Bryan A. Bernard,Marco Bozzali,Susan Bressman,Giovanna Calandra Buonaura,Francesco Cavallieri,Roberto Cilia,Jean‐Christophe Corvol,Antoniangela Cocco,Rob M. A. de Bie,Debra J. Ehrlich,Roberto Eleopra,Thomas Foltynie,Alessio Di Fonzo
摘要
BACKGROUND: Individuals with Parkinson's disease (PD) carrying GBA1 variants often develop advanced motor complications that prompt evaluation for deep brain stimulation (DBS). However, concerns about accelerated cognitive decline after DBS in GBA1 carriers complicate clinical decision making. A critical aspect that is increasingly gaining attention is the time at which DBS is performed. OBJECTIVE: The objective is to determine how the timing of DBS in relation to PD onset impacts cognitive trajectories across different GBA1 variant classes and in individuals without GBA1 variants. METHODS: A multicenter cohort study across 10 study sites in Europe and the USA was conducted. The study population comprised subjects with (GBA1-Associated Parkinson's Disease [GBA-PD]) and without GBA1 variants (nonGBA-PD), who were subjected to bilateral subthalamic nucleus (STN)-DBS. The main outcome measure was the Mattis Dementia Rating Scale (MDRS). RESULTS: A total of 343 individuals (91 GBA-PD and 252 nonGBA-PD) were included in this study. Percentile-based stratification into early and late STN-DBS treatment groups and linear mixed model analyses revealed that GBA-PD patients in the late DBS group had a significantly faster rate of cognitive decline independent of age, with sensitivity analyses identifying the 7- and 8-year cutoffs as the time points with a significant difference between early and late STN-DBS groups in GBA-PD. A negative correlation between MDRS scores and time from disease onset to STN-DBS was observed in GBA-PD, and was not present in nonGBA-PD. Cognitive trajectories were markedly worse in GBA-PD compared to nonGBA-PD, and this pattern was not influenced by the variant type. CONCLUSIONS: In GBA-PD, STN-DBS treatment at later stages is associated with greater risk of cognitive decline. Earlier STN-DBS intervention in GBA-PD may extend the period of improved motor function before the onset of significant cognitive decline. These findings highlight the potential importance of early genetic testing and disease duration when considering STN-DBS in genetically defined PD populations. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
科研通智能强力驱动
Strongly Powered by AbleSci AI